$142.12
0.93% yesterday
NYSE, Oct 15, 10:05 pm CET
ISIN
US98978V1035
Symbol
ZTS

Zoetis, Inc. Class A Stock price

$142.12
-4.13 2.82% 1M
-7.10 4.76% 6M
-20.81 12.77% YTD
-50.27 26.13% 1Y
-7.67 5.12% 3Y
-20.87 12.80% 5Y
+99.12 230.51% 10Y
+111.11 358.30% 20Y
NYSE, Closing price Wed, Oct 15 2025
-1.34 0.93%

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
$5.1b
Cash
$1.4b
Shares outstanding
444.0m
Valuation (TTM | estimate)
P/E
24.3 | 22.1
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
$1.80
Yield 1Y | 5Y
1.3% | 0.8%
Growth 1Y | 5Y
15.4% | 21.0%
Payout 1Y | 3Y
32.8% | 31.3%
Increased
12 Years
Financials (TTM | estimate)
Revenue
$9.4b | $9.6b
EBITDA
$3.7b | $4.2b
EBIT
$3.5b | $3.7b
Net Income
$2.6b | $2.9b
Free Cash Flow
$2.2b
Growth (TTM | estimate)
Revenue
5.3% | 3.9%
EBITDA
9.2% | 18.5%
EBIT
10.0% | 10.2%
Net Income
11.4% | 14.7%
Free Cash Flow
5.5%
Margin (TTM | estimate)
Gross
71.5%
EBITDA
39.1% | 43.6%
EBIT
37.7%
Net
27.8% | 29.7%
Free Cash Flow
23.6%
Financial Health
Equity Ratio
33.5%
Return on Equity
52.1%
ROCE
31.8%
ROIC
23.1%
Debt/Equity
1.3
More
EPS
$5.9
FCF per Share
$5.0
Short interest
1.8%
Employees
14k
Rev per Employee
$670.0k
Show more

Is Zoetis, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Zoetis, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Zoetis, Inc. Class A forecast:

17x Buy
71%
7x Hold
29%

Analyst Opinions

24 Analysts have issued a Zoetis, Inc. Class A forecast:

Buy
71%
Hold
29%

Financial data from Zoetis, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
9,385 9,385
5% 5%
100%
- Direct Costs 2,675 2,675
0% 0%
29%
6,710 6,710
7% 7%
71%
- Selling and Administrative Expenses 2,361 2,361
6% 6%
25%
- Research and Development Expense 682 682
3% 3%
7%
3,671 3,671
9% 9%
39%
- Depreciation and Amortization 134 134
9% 9%
1%
EBIT (Operating Income) EBIT 3,537 3,537
10% 10%
38%
Net Profit 2,612 2,612
11% 11%
28%

In millions USD.

Don't miss a Thing! We will send you all news about Zoetis, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zoetis, Inc. Class A Stock News

Neutral
Business Wire
about 21 hours ago
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Lenivia approval by Health Canada marks major milestone in the company's continued innovation for canine OA pain.
Neutral
Business Wire
6 days ago
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--If approved, Lenivia will be a new antibody therapy that reduces OA pain in dogs for three months with one injection.
Neutral
Business Wire
7 days ago
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.50 per share for the fourth quarter of 2025. The dividend will be paid on Tuesday, December 2, 2025, to all holders of record of the Company's common stock as of the close of business on Friday, October 31, 2025. About Zoetis As the world's leading animal heal...
More Zoetis, Inc. Class A News

Company Profile

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.

Head office United States
CEO Kristin Peck
Employees 13,800
Founded 1952
Website www.zoetis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today